Citizens JMP reiterates Market Outperform rating on Chewy stock ahead of earnings

Citizens JMP reiterated its Market Outperform rating and $48 price target on Chewy Inc. (NYSE:CHWY) ahead of its Q2 2026 earnings, anticipating better-than-expected results and raised forward estimates. This positive outlook stems from the ramp-up of new veterinary clinics, continued advertising growth, a healthy consumer environment, and a favorable competitive landscape. The sentiment is broadly supported by other analysts, with 10 recent upward earnings estimate revisions and consumer surveys indicating increased popularity, highlighting Chewy's strategic positioning and growth potential within the expanding pet care market.

Analysis

Chewy Inc. (CHWY) is experiencing strong positive sentiment from analysts ahead of its fiscal second-quarter 2026 results, with the stock trading near its 52-week high. Citizens JMP reiterated its Market Outperform rating and $48.00 price target, anticipating an earnings beat and a subsequent raise in forward estimates. This optimism is underpinned by several strategic initiatives, including the expansion of veterinary clinics, growth in advertising services now under direct control, and a favorable competitive landscape as rival Petco addresses operational issues. The bullish consensus is broad, evidenced by 10 recent upward earnings estimate revisions and supportive ratings from multiple firms; BofA Securities maintains a Buy rating with a $49 target, citing the $40 billion veterinary market, while Barclays holds an Overweight rating, attributing a recent 14% stock decline to a technical sale by a large investor rather than a fundamental weakness. Key long-term growth drivers include the secular trend of pet humanization within the $152 billion U.S. pet spending market, stabilizing pet household formation, and the company's high-visibility autoship subscription model, which collectively support the potential for continued EBITDA compounding.

Key Decisions for Investors

• Given the strong analyst consensus and multiple identified growth drivers, investors should view the upcoming Q2 earnings report as a significant potential catalyst for the stock.
• Monitor the company's forward guidance closely, specifically for updates on the performance of new veterinary clinics and advertising revenue, as these are central to the current bullish thesis.
• It is important to differentiate between fundamental performance and technical market factors, such as the recent $1 billion stock sale by BC Partners, when assessing price volatility.
• Consider Chewy's strengthening competitive moat, as its primary rival Petco is reportedly focused on internal operational improvements, potentially allowing Chewy to capture additional market share.